Bristol-Myers Squibb Co PE Ratio
Data as of August 04, 2026
PE Ratio (TTM)
22.31
Stock Price
$65.47
EPS (TTM)
$3.36
Forward PE
10.35
How It's Calculated
22.31 = $65.47 ÷ $3.36
What This Means
Bristol-Myers Squibb Co's PE ratio of 22.3 is in the moderate range, typical of established companies with steady earnings growth.
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Co (BMY) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $133.41B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $65.47, within a 52-week range of $42.52 to $65.66 (-0.3% from the high, +54.0% from the low). Beta of 0.23 indicates relatively lower volatility versus the market.
Trailing profit margin is about 12.3%, signaling a solid profit margin for its industry.
Understanding This Metric
The PE ratio is one of the most widely cited valuation multiples. For Bristol-Myers Squibb Co, it reflects how much investors pay today for each dollar of trailing earnings. High-growth Pharmaceuticals names often carry elevated PE ratios when the market prices in faster future profits, while mature companies with stable cash flows may trade at lower multiples even in the same sector.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Bristol-Myers Squibb Co's PE ratio of 22.31 can be compared with peers such as LLY (42.80), JNJ (29.37), MRK (35.99). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- BMY is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.23 suggests lower-than-market price sensitivity.
- Trailing profit margin of 12.3% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for BMY.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →PEG Ratio
-8.67
Sector
Pharmaceuticals
Other BMY Metrics
Frequently Asked Questions
What does BMY's PE ratio mean?
The PE ratio shows how much investors pay per dollar of trailing earnings for Bristol-Myers Squibb Co. A trailing PE of 22.31 means the market is pricing the stock at 22.31 times last twelve months' EPS — useful for comparing valuation across time and versus Pharmaceuticals peers, not as a buy/sell signal on its own.
Is 22.31 high or low vs sector peers?
Among Pharmaceuticals names in our S&P 100 coverage, peers such as PFE (19.03), JNJ (29.37), MRK (35.99) offer context. BMY's PE of 22.31 should be read with growth, margins, and balance-sheet risk — high PE can mean strong growth expectations; low PE can mean value or weaker outlook.
How often is this PE updated?
StockCalc refreshes BMY metrics on U.S. trading days; this page shows data as of August 04, 2026. PE moves with price daily and with EPS when companies report earnings.
Calculate the pe ratio for any stock with our free calculator.
Open PE Ratio Calculator →